CIK 0002000775 · <br>Emerging growth company
Black Hawk Acquisition Corp
Sign in to watch- Ticker
- BKHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Nov 30
- Entity type
- operating
- Phone
- 203-520-7122
- Business address
- 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE, CA, 94506
Securities
- BKHA Class A Ordinary Shares Nasdaq
- BKHAR Rights Nasdaq
- BKHAU Units Nasdaq
- 8-K Event Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DRS Other Draft Registration Statement
- DEFR14A Other DEFR14A
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
Page 4 of 6 · 119 filings